Main strategies of plant expression system glycoengineering for producing humanized recombinant pharmaceutical proteins

Most the pharmaceutical proteins are derived not from their natural sources, rather their recombinant analogs are synthesized in various expression systems. Plant expression systems, unlike mammalian cell cultures, combine simplicity and low cost of procaryotic systems and the ability for posttransl...

Full description

Bibliographic Details
Published in:Biochemistry (Moscow) Vol. 83, № 3. P. 215-232
Main Author: Rozov, Sergey M.
Other Authors: Permyakova, N. V., Deineko, Elena V.
Format: Article
Language:English
Subjects:
Online Access:http://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000723631
Перейти в каталог НБ ТГУ
LEADER 02616nab a2200361 c 4500
001 vtls000723631
003 RU-ToGU
005 20230319220624.0
007 cr |
008 200902|2018 ru s a eng dd
024 7 |a 10.1134/S0006297918030033  |2 doi 
035 |a to000723631 
039 9 |a 202009071334  |c 202009021611  |d VLOAD  |y 202009021551  |z Александр Эльверович Гилязов 
040 |a RU-ToGU  |b rus  |c RU-ToGU 
100 1 |a Rozov, Sergey M.  |9 482554 
245 1 0 |a Main strategies of plant expression system glycoengineering for producing humanized recombinant pharmaceutical proteins  |c S. M. Rozov, N. V. Permyakova, E. V. Deineko 
504 |a Библиогр.: 144 назв. 
520 3 |a Most the pharmaceutical proteins are derived not from their natural sources, rather their recombinant analogs are synthesized in various expression systems. Plant expression systems, unlike mammalian cell cultures, combine simplicity and low cost of procaryotic systems and the ability for posttranslational modifications inherent in eucaryotes. More than 50% of all human proteins and more than 40% of the currently used pharmaceutical proteins are glycosylated, that is, they are glycoproteins, and their biological activity, pharmacodynamics, and immunogenicity depend on the correct glycosylation pattern. This review examines in detail the similarities and differences between N- and O-glycosylation in plant and mammalian cells, as well as the effect of plant glycans on the activity, pharmacokinetics, immunity, and intensity of biosynthesis of pharmaceutical proteins. The main current strategies of glycoengineering of plant expression systems aimed at obtaining fully humanized proteins for pharmaceutical application are summarized. 
653 |a гликозилирование белков 
653 |a гликозилирование 
653 |a фармацевтические белки 
653 |a растительные системы экспрессии 
653 |a гликозилтрансферазы 
653 |a гликоинженерия 
655 4 |a статьи в журналах  |9 879358 
700 1 |a Permyakova, N. V.  |9 502647 
700 1 |a Deineko, Elena V.  |9 104810 
773 0 |t Biochemistry (Moscow)  |d 2018  |g Vol. 83, № 3. P. 215-232  |x 0006-2979 
852 4 |a RU-ToGU 
856 4 |u http://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000723631 
856 |y Перейти в каталог НБ ТГУ  |u https://koha.lib.tsu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=466994 
908 |a статья 
999 |c 466994  |d 466994